EUVIMEDEUVIMED entdecken
Fallbericht

Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease

Moras Patrizio iD, Pilati Mara, Rebonato Micol iD, Butera Gianfranco

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31382 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Moras Patrizio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fetal, Neonatal and Cardiovascular Sciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Coronary Aneurysm, Tissue Plasminogen Activator, Fibrinolytic Agents. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kawasaki Disease (KD) is a systemic vasculitis that can lead to coronary artery aneurysms (CAA) in up to 10% of treated cases, significantly increasing the risk of thrombosis and acute myocardial infarction (AMI). While thrombolytic therapy is commonly used in adult coronary syndromes, its application in pediatric KD remains poorly studied. We report a 9‐month‐old infant with KD and giant CAA complicated by a subocclusive thrombus in the left anterior descending artery (LAD). Initial systemic intravenous thrombolysis (IVCT) with alteplase failed to prevent progression to ST‐elevation myocardial infarction (STEMI). Intracoronary thrombolysis (ICT) was subsequently performed, achieving partial reperfusion without complications. At 18 months of follow‐up, the patient remained asymptomatic with stable left ventricular dysfunction. This single case illustrates the potential feasibility of combining ICT and IVCT in managing coronary thrombosis in pediatric KD. However, as a single observation, these findings cannot be generalized, and the approach requires further investigation. Robust multicenter studies are necessary to establish the safety, efficacy, and optimal use of thrombolytic therapy in pediatric KD patients with coronary thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeCoronary AneurysmTissue Plasminogen ActivatorFibrinolytic AgentsThrombolytic TherapyCoronary ThrombosisCoronary OcclusionHumansTreatment OutcomeInfantCoronary AngiographyMale

Substanzen

Tissue Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Fetal, Neonatal and Cardiovascular Sciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

ORCID-Profile: Moras Patrizio, Rebonato Micol

Zitieren

APA

Patrizio, M., Mara, P., Micol, R., & Gianfranco, B. (2025). Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31382

Vancouver

Patrizio M, Mara P, Micol R, Gianfranco B. Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31382

BibTeX
@article{Patrizio2025,
  author = {Patrizio, Moras and Mara, Pilati and Micol, Rebonato and Gianfranco, Butera},
  title = {Intracoronary Tissue Plasminogen Activator Therapy to Treat Thrombotic Occlusion of a Giant Coronary Aneurysm in Early Kawasaki Disease},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31382}
}
Kostenlos starten →